The pharma company said asundexian, when combined with antiplatelet therapy, lowered the risk of stroke in patients during ...

Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals.

Shares in Bayer jumped more than 8% on Monday after initial clinical trial results turned around the fortunes of a key ...

Bayer shares surge after its asundexian stroke drug shows positive Phase III results, offering a key boost to its pipeline ...

German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a ...

Investing.com -- Bayer’s (ETR:BAYGN) experimental stroke drug could generate €3 billion in annual sales after successful trial results that Goldman Sachs analyst James Quigley called "transformational ...

Bayer has let go of about 13,500 employees, including around 5,000 managers, since implementing a new operating model in ...

The Chinese e-commerce leader said its Qwen artificial-intelligence app drew more than 10 million downloads i ...

The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...

The soybean production facility hones in on quality over quantity of their product, with 2.8 million soybean bags leaving the ...